Condition: Diabetic Foot Ulcer (DFU) · Ulcer Foot · Diabetic Foot · Sponsor: StimLabs
The purpose of this study is to evaluate the efficacy of four dehydrated complete human placental membrane, also defined as Cellular, Acellular, Matrix-like Products/skin substitutes, plus SOC versus SOC alone in achieving complete closure of hard-to-heal diabetic foot ulcers over 12 weeks using a modified platform trial design.
This description comes directly from the study's public registry record.
Kristy Breisinger · 888-960-1343 · kbreisinger@serenagroups.com
Thomas Serena, MD · 814-688-4000 · serena@serenagroups.com
Always discuss trial participation with your own doctor first.
| SerenaGroup Omaha Research Center | Omaha, Nebraska, United States | Recruiting |
| Wound Care of Tulsa | Tulsa, Oklahoma, United States | Recruiting |
| SerenaGroup Research South | Jefferson Hills, Pennsylvania, United States | Not Yet Recruiting |
| Armstrong County Memorial Hospital | Kittanning, Pennsylvania, United States | Not Yet Recruiting |
| SerenaGroup Monroeville | Monroeville, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06449638